STAT

JUNE 8, 2025

Four members of the 19-person expert panel that advises the Centers for Disease Control and Prevention on vaccination policy have been informed that their status as special government employees has been terminated — a development that throws into question their ability to continue to work on the body, STAT has learned. The Advisory Committee on Immunization Practices has been in the crosshairs of health secretary Robert F.

Vaccines 362

Vaccines Immunity Immunization 362

Express Pharma

JUNE 8, 2025

According to the GlobalData report, the global pharma industry reported 76 mergers and acquisitions (M&A) deals in May 2025, amounting to a total disclosed value of $6.96 billion. This figure marks a decline compared to the previous 12-month average from May 2024 to April 2025, which recorded 95 deals worth $12.4 billion. According to industry data, three major transactions contributed 59 per cent of the total deal value in May.

100

100

Med Ed 101

JUNE 8, 2025

Angiotensin II receptor blockers (ARBs) are widely used in managing hypertension, heart failure, chronic kidney disease (CKD), and diabetic nephropathy. While these agents share a common mechanism—blocking the angiotensin II type 1 (AT₁) receptor—not all ARBs are created equal. As healthcare professionals, understanding the nuanced differences can guide therapy optimization, especially in patients with comorbidities […] The post Losartan Differences – A Deep Dive on ARBs appeared fir

Diabetes 94

Diabetes 94

Pharmacy Joe

JUNE 8, 2025

In this episode, I’ll discuss outcomes with doxycycline vs azithromycin for community-acquired pneumonia. Episode 1033: Doxycycline Might Not Be As Good As We Thought. Subscribe on iTunes , Android , or Stitcher Doxycycline is used as an alternative to azithromycin in combination with a beta-lactam to treat community-acquired pneumonia severe enough to be hospitalized.

Hospitals 40

Hospitals Inpatient 40

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharmacy Times

JUNE 8, 2025

Innovative pain management strategies emerge as experts advocate for personalized, multifaceted approaches to chronic pain, likening treatment to a tailored cupcake.

35

35

Pharmacy Times

JUNE 8, 2025

Ambulatory pharmacists innovate care delivery, enhancing patient access and outcomes through home visits and harm reduction clinics for complex health needs.

29

29

Board Vitals - Pharmacist

JUNE 8, 2025

If you’re on the path to becoming a licensed nurse, you know that passing the NCLEX® is key. But with recent declines in pass rates, it’s more important than ever to prepare effectively. Let’s look at the drop in NCLEX pass rates and explore strategies and resources that can make a real difference in your study routine. Why are NCLEX Pass Rates Decreasing?

52

52

Pharmacy Times

JUNE 8, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Pharmacy Technician 29

Pharmacy Technician Specialty Pharmacies Communication Immunization 29

FDA Law Blog: Biosimilars

JUNE 8, 2025

By Sara W. Koblitz — It was about a year and a half ago that we first proclaimed mass hysteria when FTC crossed streams into FDA territory, but perhaps our cries were premature. As we mentioned last year, a large number of the drug companies targeted by FTC in its Orange Book delisting campaign refused to delist their device patents from the Orange Book.

59

59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication